Omega Fund IV, L.P.
SEC CIK 1528382 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Dir, 10% | 4.91M | — | $3.30M | 1 | 2021-09-16 | 2021-09-16 |
Most active insiders at REPL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sushil | CEO, Dir | — | $811.2K |
| 2 | Hill Emily Luisa | CFO | — | $320.3K |
| 3 | Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| 4 | Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| 5 | Schwendenman Andrew | CAO | — | $139.1K |
| 6 | Astley-Sparke Philip | Dir | — | $89.7K |
| 7 | Dhingra Kapil | Dir | — | $33.0K |
Omega Fund IV, L.P. made no open-market trades at REPL in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-20 | 2021-09-16+ | REPL | Replimune Group, Inc. | Omega Fund IV, L.P. | Dir, 10% | S - Sale | $32.99 | -100.0K | 4.91M | -2% | -$3.30M |
Purchase Sale Sale after option exercise All abbreviations